Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	Ribosomal_L10e_CS	RPL10L RPL10	2.35e-05	2	91	2	IPR018255
Domain	Ribosomal_L10e	RPL10L RPL10	2.35e-05	2	91	2	IPR001197
Domain	RIBOSOMAL_L10E	RPL10L RPL10	2.35e-05	2	91	2	PS01257
Domain	Ribosomal_L10e/L16	RPL10L RPL10	7.02e-05	3	91	2	IPR016180
Domain	-	RPL10L RPL10	7.02e-05	3	91	2	3.90.1170.10
Domain	Ribosomal_L16	RPL10L RPL10	7.02e-05	3	91	2	PF00252
Domain	PPR	LRPPRC DENND4C	1.40e-04	4	91	2	PF01535
Domain	PKNOX/Meis_N	MEIS3 MEIS2	2.33e-04	5	91	2	IPR032453
Domain	Meis_PKNOX_N	MEIS3 MEIS2	2.33e-04	5	91	2	PF16493
Domain	PPR	LRPPRC DENND4C	6.45e-04	8	91	2	PS51375
Domain	BROMODOMAIN_1	BRDT CREBBP BRWD3	7.71e-04	37	91	3	PS00633
Domain	Bromodomain	BRDT CREBBP BRWD3	8.34e-04	38	91	3	PF00439
Domain	BROMODOMAIN_2	BRDT CREBBP BRWD3	1.04e-03	41	91	3	PS50014
Domain	BROMO	BRDT CREBBP BRWD3	1.12e-03	42	91	3	SM00297
Domain	Bromodomain	BRDT CREBBP BRWD3	1.12e-03	42	91	3	IPR001487
Domain	-	BRDT CREBBP BRWD3	1.12e-03	42	91	3	1.20.920.10
Domain	Dynein_HC_stalk	DNHD1 DNAH14	2.06e-03	14	91	2	IPR024743
Domain	MT	DNHD1 DNAH14	2.06e-03	14	91	2	PF12777
Domain	DHC_fam	DNHD1 DNAH14	2.37e-03	15	91	2	IPR026983
Domain	Dynein_heavy_dom	DNHD1 DNAH14	2.37e-03	15	91	2	IPR004273
Domain	Dynein_heavy	DNHD1 DNAH14	2.37e-03	15	91	2	PF03028
Domain	PBD	PAK3 CDC42EP1	2.70e-03	16	91	2	SM00285
Domain	C1_1	UNC13C DGKH RASGRP2	2.71e-03	57	91	3	PF00130
Domain	Homeobox_KN	MEIS3 MEIS2	3.04e-03	17	91	2	PF05920
Domain	Homeobox_KN_domain	MEIS3 MEIS2	3.04e-03	17	91	2	IPR008422
Domain	PBD	PAK3 CDC42EP1	3.04e-03	17	91	2	PF00786
Domain	CarboxyPept-like_regulatory	TENM4 CILP	3.04e-03	17	91	2	IPR008969
Domain	ZF_DAG_PE_1	UNC13C DGKH RASGRP2	3.76e-03	64	91	3	PS00479
Domain	ZF_DAG_PE_2	UNC13C DGKH RASGRP2	3.76e-03	64	91	3	PS50081
Domain	C1	UNC13C DGKH RASGRP2	3.93e-03	65	91	3	SM00109
Domain	PE/DAG-bd	UNC13C DGKH RASGRP2	4.10e-03	66	91	3	IPR002219
Domain	CRIB	PAK3 CDC42EP1	4.21e-03	20	91	2	PS50108
Domain	CRIB_dom	PAK3 CDC42EP1	4.64e-03	21	91	2	IPR000095
Pubmed	Identification of a conserved family of Meis1-related homeobox genes.	MEIS3 MEIS2 MEIS3P1	7.88e-08	4	95	3	9049632
Pubmed	When integrins fail to integrate.	FERMT3 RASGRP2	7.38e-06	2	95	2	19265824
Pubmed	Regulation of RB1CC1/FIP200 stability and autophagy function by CREBBP-mediated acetylation in an intrinsically disordered region.	RB1CC1 CREBBP	7.38e-06	2	95	2	36394358
Pubmed	Novel variants in FERMT3 and RASGRP2-Genetic linkage in Glanzmann-like bleeding disorders.	FERMT3 RASGRP2	7.38e-06	2	95	2	31724816
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MBTPS1 LRPPRC NEMF SEL1L3 PAK3 TTC17 DGKH CHD2 MEIS3 WDR25 EIF4G3 CREBBP BRWD3 DNAH14 SH3BP4	1.22e-05	1489	95	15	28611215
Pubmed	Acetylation promotes BCAT2 degradation to suppress BCAA catabolism and pancreatic cancer growth.	BCAT2 CREBBP	2.21e-05	3	95	2	32467562
Pubmed	An autoinhibitory effect of the homothorax domain of Meis2.	MEIS3 MEIS2	2.21e-05	3	95	2	20553494
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	PELO RFC4 ZBTB7B DENND4C RPL10 UTP14C CDC42EP1	2.95e-05	321	95	7	32098917
Pubmed	The human EKC/KEOPS complex is recruited to Cullin2 ubiquitin ligases by the human tumour antigen PRAME.	UBL4A RFC4 RPL10	3.36e-05	23	95	3	22912744
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	PABPN1 RRS1 NEMF RFC4 EIF4G3 ZC3H7B EXOC7 RPL10 NOL8 NCBP3	4.40e-05	759	95	10	35915203
Pubmed	Pelota interacts with HAX1, EIF3G and SRPX and the resulting protein complexes are associated with the actin cytoskeleton.	PELO SRPX	4.41e-05	4	95	2	20406461
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SLIT2 ARSB PELO BRDT ARHGAP23 CHAF1A OAS3 BICRAL RFC4 CREBBP BRWD3 CDC42EP1	5.30e-05	1116	95	12	31753913
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	LRPPRC PABPN1 RRS1 DHX38 CHD2 EIF4G3 ZC3H7B RPL10 NOL8 NCBP3	7.32e-05	807	95	10	22681889
Pubmed	The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3.	IKBKE CREBBP	7.34e-05	5	95	2	20581830
Pubmed	Involvement of the IkappaB kinase (IKK)-related kinases tank-binding kinase 1/IKKi and cullin-based ubiquitin ligases in IFN regulatory factor-3 degradation.	IKBKE CREBBP	7.34e-05	5	95	2	17015689
Pubmed	Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain.	DHX38 BICRAL RB1CC1 UTP14C	8.14e-05	83	95	4	9039502
Pubmed	High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.	EHBP1L1 PABPN1 RRS1 BCAT2 DGKH CHD2 ZBTB7B ZNF692 BRWD3 MEIS2 SAMD4A	1.09e-04	1021	95	11	26760575
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	BRDT PABPN1 RRS1 CHAF1A DHX38 TTC17 CHD2 RFC4	1.09e-04	533	95	8	30554943
Pubmed	A conserved non-homeodomain Hoxa9 isoform interacting with CBP is co-expressed with the 'typical' Hoxa9 protein during embryogenesis.	CREBBP MEIS2	1.10e-04	6	95	2	15161102
Pubmed	Tisp40, a spermatid specific bZip transcription factor, functions by binding to the unfolded protein response element via the Rip pathway.	MBTPS1 UTP14C	1.10e-04	6	95	2	15938716
Pubmed	Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity.	IKBKE CREBBP	1.10e-04	6	95	2	34239064
Pubmed	Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.	LRPPRC EHBP1L1 RRS1 OAS3 PTGS1 NCBP3 CDC42EP1	1.23e-04	403	95	7	35253629
Pubmed	Regulation of EphA8 gene expression by TALE homeobox transcription factors during development of the mesencephalon.	MEIS3 MEIS2	1.54e-04	7	95	2	17178831
Pubmed	PBX, MEIS, and IGF-I are potential mediators of retinoic acid-induced proximodistal limb reduction defects.	MEIS3 MEIS2	1.54e-04	7	95	2	12397630
Pubmed	Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis.	MEIS3 MEIS2	2.62e-04	9	95	2	12183364
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	GABRB3 R3HDM4 PABPN1 EIF4G3 ACSL5 SAMD4A NCBP3	2.82e-04	462	95	7	31138677
Pubmed	A comparative transcriptional map of a region of 250 kb on the human and mouse X chromosome between the G6PD and the FLN1 genes.	UBL4A RPL10	3.28e-04	10	95	2	7490070
Pubmed	Identification of a new family of Pbx-related homeobox genes.	MEIS3 MEIS2	3.28e-04	10	95	2	8950991
Pubmed	Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein.	TAF1A CREBBP	3.28e-04	10	95	2	11163245
Pubmed	Rostral hindbrain patterning involves the direct activation of a Krox20 transcriptional enhancer by Hox/Pbx and Meis factors.	MEIS3 MEIS2	4.00e-04	11	95	2	18787068
Pubmed	Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation.	RIPOR3 PTGS1 MEIS2	4.67e-04	55	95	3	24200680
Pubmed	Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype.	MEIS3 MEIS2	5.65e-04	13	95	2	16847320
Pubmed	Pax6 is regulated by Meis and Pbx homeoproteins during pancreatic development.	MEIS3 MEIS2	5.65e-04	13	95	2	17049510
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	LRPPRC IKBKE CEP162 EIF4G3 DENND4C E2F8 SAMD4A SH3BP4 CDC42EP1	5.90e-04	861	95	9	36931259
Pubmed	Long-range sequence analysis in Xq28: thirteen known and six candidate genes in 219.4 kb of high GC DNA between the RCP/GCP and G6PD loci.	UBL4A RPL10	6.58e-04	14	95	2	8733135
Pubmed	Range of HOX/TALE superclass associations and protein domain requirements for HOXA13:MEIS interaction.	MEIS3 MEIS2	6.58e-04	14	95	2	15617687
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	TFCP2L1 CHAF1A TAF1A MEIS3 ZBTB7B CREBBP MXD4 MEIS2 E2F8	6.72e-04	877	95	9	20211142
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CHMP7 LRPPRC RRS1 PARL UBL4A TTC17 RB1CC1 EIF4G3 NOL8 NCBP3 SH3BP4 CDC42EP1	7.35e-04	1487	95	12	33957083
Pubmed	Dynamic expression of MEIS1 homeoprotein in E14.5 forebrain and differentiated forebrain-derived neural stem cells.	MEIS3 MEIS2	7.57e-04	15	95	2	23756022
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	LRPPRC PELO IKBKE CEP162 CHAF1A DHX38 RB1CC1 RFC4 EIF4G3 SAMD4A SH3BP4	7.62e-04	1284	95	11	17353931
Pubmed	Distal Limb Patterning Requires Modulation of cis-Regulatory Activities by HOX13.	TENM4 MEIS2	8.64e-04	16	95	2	27974206
Pubmed	Slit2 activity in the migration of guidepost neurons shapes thalamic projections during development and evolution.	SLIT2 MEIS2	9.78e-04	17	95	2	21435555
Pubmed	RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly.	RB1CC1 EXOC7	9.78e-04	17	95	2	21241894
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	SLIT2 R3HDM4 CEP162 TAF1A MEIS3 EIF4G3 EXOC7 DNAH14 NUBP2	9.78e-04	925	95	9	28986522
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	TRMU MBTPS1 PELO FAR2 CHAF1A DHX38 PARL UBL4A MEIS3 FAM186B MEIS2	9.96e-04	1327	95	11	32694731
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	ARHGAP23 MEIS3P2 MEIS3P1	1.11e-03	74	95	3	16625196
Pubmed	Meis2 Is Required for Inner Ear Formation and Proper Morphogenesis of the Cochlea.	MYO7B MEIS2	1.22e-03	19	95	2	34124068
Pubmed	Genes, plasticity and mental retardation.	PAK3 CREBBP	1.22e-03	19	95	2	18329113
Pubmed	Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN.	ZBTB7B ZNF692	1.22e-03	19	95	2	30385546
Pubmed	A novel common variant in DCST2 is associated with length in early life and height in adulthood.	TTC17 ZBTB7B	1.36e-03	20	95	2	25281659
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	LRPPRC PELO PABPN1 UBL4A UNC13C RFC4 VBP1 RPL10 UTP14C	1.37e-03	971	95	9	33306668
Pubmed	Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.	EHBP1L1 SEL1L3	1.50e-03	21	95	2	20708005
Pubmed	Mapping the Genetic Landscape of Human Cells.	PELO TAF1A NEMF RFC4 RPL10 NOL8	1.51e-03	451	95	6	30033366
Pubmed	The atypical homeoprotein Pbx1a participates in the axonal pathfinding of mesencephalic dopaminergic neurons.	MEIS3 MEIS2	1.65e-03	22	95	2	22748019
Pubmed	Stromal netrin 1 coordinates renal arteriogenesis and mural cell differentiation.	MEIS3 MEIS2	1.65e-03	22	95	2	37823339
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	LRPPRC CTTNBP2 TAF1A DHX38 UBL4A SRPX RFC4 EIF4G3 VBP1	1.73e-03	1005	95	9	19615732
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DNHD1 LRPPRC PABPN1 RRS1 CHAF1A DHX38 NEMF KIF3C RFC4 CCDC38 RPL10	1.76e-03	1425	95	11	30948266
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	TRMU CTTNBP2 ARHGAP23 ADAM23 GRK5 RIPOR3 CHD2 EIF4G3 DNAH14 DENND4C	1.80e-03	1215	95	10	15146197
Pubmed	Pbx1/Pbx2 govern axial skeletal development by controlling Polycomb and Hox in mesoderm and Pax1/Pax9 in sclerotome.	MEIS3 MEIS2	1.80e-03	23	95	2	18691704
Pubmed	Physical mapping of the mouse tilted locus identifies an association between human deafness loci DFNA6/14 and vestibular system development.	OTOP1 CLNK	1.80e-03	23	95	2	11597144
Pubmed	β-dystroglycan is regulated by a balance between WWP1-mediated degradation and protection from WWP1 by dystrophin and utrophin.	PI4K2A RPL10	1.96e-03	24	95	2	29635000
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	SLIT2 TENM4 ARHGAP23 GRK5 NEMF RPL10	1.96e-03	475	95	6	31040226
Pubmed	Dengue hemorrhagic fever is associated with polymorphisms in JAK1.	IKBKE OAS3 CREBBP	2.02e-03	91	95	3	20588308
Pubmed	Identification and characterization of cellular heterogeneity within the developing renal interstitium.	MEIS3 MEIS2	2.13e-03	25	95	2	32586976
Pubmed	Klf4 and corticosteroids activate an overlapping set of transcriptional targets to accelerate in utero epidermal barrier acquisition.	FAR2 PTGS1	2.13e-03	25	95	2	17130451
Pubmed	ZNF750 Regulates Skin Barrier Function by Driving Cornified Envelope and Lipid Processing Pathways.	FAR2 ZBTB7B	2.13e-03	25	95	2	37660780
Pubmed	A human MAP kinase interactome.	CHAF1A PAK3 BICRAL CREBBP SH3BP4 CDC42EP1	2.20e-03	486	95	6	20936779
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	SLIT2 LRPPRC RRS1 NEMF RFC4 NUBP2	2.20e-03	486	95	6	30940648
Pubmed	Loss of the transcription factor Meis1 prevents sympathetic neurons target-field innervation and increases susceptibility to sudden cardiac death.	MEIS3 MEIS2	2.30e-03	26	95	2	26857994
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SHROOM4 CTTNBP2 ARHGAP23 DHX38 EXOC7 UTP14C	2.36e-03	493	95	6	15368895
Pubmed	Requirement for Pbx1 in skeletal patterning and programming chondrocyte proliferation and differentiation.	MEIS3 MEIS2	2.48e-03	27	95	2	11566859
Pubmed	Robo1 modulates proliferation and neurogenesis in the developing neocortex.	SLIT2 RB1CC1	2.48e-03	27	95	2	24741061
Pubmed	ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.	DNHD1 CREBBP	2.48e-03	27	95	2	17525332
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	CHMP7 CHAF1A EIF4G3 EXOC7 DENND4C SH3BP4	2.61e-03	503	95	6	16964243
GeneFamily	TALE class homeoboxes and pseudogenes	MEIS3P2 MEIS3 MEIS2 MEIS3P1	1.35e-06	26	58	4	526
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	TRMU R3HDM4 PABPN1 TTC17 ZC3H7B ZBTB7B ZNF692 GRAMD4 NOL8 CDC42EP1	4.26e-07	338	95	10	M17094
Coexpression	HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL	ARSB PELO FAR2 MTERF2 SEL1L3 BCAT2 CLNK ACSL5	2.61e-05	328	95	8	M45723
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_UP	GABRB3 TFCP2L1 BRDT NIPA1 EIF4G3 CREBBP	4.60e-05	177	95	6	M9118
Coexpression	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	DNHD1 EHBP1L1 PABPN1 CHD2 GRAMD4 ACSL5	5.71e-05	184	95	6	M19988
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_UP	GABRB3 TFCP2L1 BRDT NIPA1 EIF4G3 CREBBP	7.23e-05	192	95	6	MM752
Coexpression	GSE20727_CTRL_VS_H2O2_TREATED_DC_UP	SIDT2 R3HDM4 PI4K2A EIF4G3 ZBTB7B RASGRP2	8.57e-05	198	95	6	M9245
Coexpression	GENTILE_UV_LOW_DOSE_DN	SLIT2 EIF4G3 MEIS2 SAMD4A	8.71e-05	64	95	4	M4594
Coexpression	GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP	MBTPS1 FAR2 MTERF2 CHD2 BRWD3 RASGRP2	9.05e-05	200	95	6	M9391
Coexpression	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP	PI4K2A KIF3C EXOC7 CREBBP BRWD3 RASGRP2	9.05e-05	200	95	6	M3614
Coexpression	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN	TRMU CHAF1A EXOC7 MXD4 VBP1 DENND4C	9.05e-05	200	95	6	M8869
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD5 ARSB PELO DGKH MEIS3	1.17e-05	138	95	5	19ffd66256fa94d728138d37d0a5a3bac7722dbb
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD5 ARSB PELO DGKH MEIS3	1.17e-05	138	95	5	321070b6900887b27da0f2b25808a05a8ab89ee7
ToppCell	facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IKBKE OAS3 WDR25 BRWD3 NOL8	1.54e-05	146	95	5	26493014daa432db721613ef480d133f3da9eb58
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CD5 ARHGAP23 CYP46A1 BRWD3 NOL8	1.54e-05	146	95	5	cffa91d76606f74553d81150adbb23b003746316
ToppCell	15-Distal-Immune-Immune\|Distal / Age, Tissue, Lineage and Cell class	DRC7 RIPOR3 PTGS1 FERMT3 RASGRP2	2.54e-05	162	95	5	e190c496ed1e206b86566edfee23c99a99fe90d0
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|World / disease group, cell group and cell class (v2)	TENM4 CHAF1A NIPA1 CYP46A1 SH3BP4	2.94e-05	167	95	5	bf08f17965a4dd03f371b4ed0ab0d5e62ed61307
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	TENM4 CHAF1A NIPA1 CYP46A1 SH3BP4	3.02e-05	168	95	5	968405ea56f7d001ef83ff9274610923c3b2d55d
ToppCell	wk_08-11-Hematologic-Meg-ery-Megakaryocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FAR2 RIPOR3 PTGS1 FERMT3 RASGRP2	3.29e-05	171	95	5	9dda25df493766723335851b3c3d89735b6e8051
ToppCell	mild_COVID-19-pDC\|World / disease group, cell group and cell class (v2)	SEL1L3 SRPX FAM186B CYP46A1 SH3BP4	3.38e-05	172	95	5	dab2f1a05c7df58d9387b13271b3f1f1583f9ac3
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PAK3 KIF3C WDR25 MEIS2 SAMD4A	3.47e-05	173	95	5	85083b9ce20351dd69aa2327ad087b848b4307ff
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	R3HDM4 RIPOR3 PTGS1 FERMT3 RASGRP2	3.67e-05	175	95	5	c33317d8d60ea88ec326daf91dfd3416a62f9938
ToppCell	ASK440-Immune-Mast_cell\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	CTTNBP2 CLNK PTGS1 MEIS2 RPL10	3.98e-05	178	95	5	dcefc4afca3a40d1bd44722e66bca6b45a6c6c55
ToppCell	COVID-19-Myeloid-MoAM4\|Myeloid / Condition, Lineage and Cell class	CTTNBP2 CD5 CHAF1A SEL1L3 DNAH14	3.98e-05	178	95	5	fe0017e6a1f23dc45f644b9acacc7e8aa80d0116
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	R3HDM4 RIPOR3 PTGS1 FERMT3 RASGRP2	4.42e-05	182	95	5	e5e16abf4d3bd5a97e7c573b99f7a3d9a5add120
ToppCell	T_cells-Resident_memory_CD8+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	CTTNBP2 PELO SEL1L3 BCAT2 CLNK	4.42e-05	182	95	5	111d434b89902ec11fb07f41b8ee1a98f3991b61
ToppCell	COVID-19-kidney-CD-IC-A\|kidney / Disease (COVID-19 only), tissue and cell type	SLIT2 TFCP2L1 CTTNBP2 CLNK SH3BP4	4.54e-05	183	95	5	5c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLIT2 TENM4 CILP GRK5 SRPX	4.78e-05	185	95	5	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-naive_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARSB RRS1 BCAT2 ZNF692 PTGS1	4.91e-05	186	95	5	744bf39af2fb5a7454477174d7755a6d78cd279f
ToppCell	control-Myeloid-pDC\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SEL1L3 SRPX CYP46A1 CTSV SH3BP4	4.91e-05	186	95	5	fe31e9cf4575ee40b50489593c51d8c36c3cc532
ToppCell	Control-Endothelial-VE_Venous\|World / Disease state, Lineage and Cell class	SHROOM4 ARHGAP23 SRPX PTGS1 MEIS2	5.29e-05	189	95	5	f83f7521e377ded1522639e9a35c98b3e2725bac
ToppCell	critical-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TFCP2L1 SIDT2 CTTNBP2 UNC13C CLNK	5.43e-05	190	95	5	05a2c3549b68f49081723bf35db14974274419d5
ToppCell	Control-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	SHROOM4 ARSB ADAM23 SRPX PTGS1	5.43e-05	190	95	5	4e30155203b4a8c5e496fcbe9348b67b98ebc625
ToppCell	Control-Endothelial-VE_Venous\|Control / Disease state, Lineage and Cell class	SHROOM4 ARHGAP23 SRPX PTGS1 MEIS2	5.56e-05	191	95	5	617546cf4883dedf3323e03a53ba5adec334cf8e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TENM4 DGKH DNAH14 SAMD4A SH3BP4	5.56e-05	191	95	5	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TENM4 DGKH DNAH14 SAMD4A SH3BP4	5.56e-05	191	95	5	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	IPF-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	TFCP2L1 SEL1L3 ACSL5 SAMD4A CDC42EP1	5.70e-05	192	95	5	356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2
ToppCell	facs-Brain_Non-Myeloid-Striatum\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB3 PAK3 NIPA1 REM2 MEIS2	5.84e-05	193	95	5	d8ccfb780a75bdf9141f41fb29a076958601ebb4
ToppCell	IPF-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	SHROOM4 ARSB SRPX PTGS1 MEIS2	5.99e-05	194	95	5	e8a9005963704286bcc50785bda8d7d63ec001b1
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical\|TCGA-Thryoid / Sample_Type by Project: Shred V9	SHROOM4 EHBP1L1 ARHGAP23 SEL1L3 CDC42EP1	5.99e-05	194	95	5	b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SLIT2 TENM4 PAK3 SRPX CDC42EP1	6.14e-05	195	95	5	ec12cfb2fce44cc2de4e198ef5af075e626f0329
ToppCell	10x5'-lymph-node_spleen\|World / Manually curated celltypes from each tissue	CHMP7 CD5 SEL1L3 RPL10 RASGRP2	6.29e-05	196	95	5	2951be22ab9095c4d3286c69dc4ab3308287c145
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM4 MYO7B OAS3 GRAMD4	6.51e-05	101	95	4	86acaa2502f61baa714ae988b73e3e73a71e897e
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	SLIT2 CILP IKBKE MTERF2 UNC13C	6.60e-05	198	95	5	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	distal-1-Endothelial-Vein\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SHROOM4 ADAM23 SRPX PTGS1 MEIS2	6.60e-05	198	95	5	eee6cb4fe0e1caf460869d5a0a57c9d259573f10
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLIT2 TENM4 MEIS3 SRPX MEIS2	6.60e-05	198	95	5	cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SHROOM4 ARHGAP23 ADAM23 SRPX MEIS2	6.75e-05	199	95	5	53b6a661d381b1ed3ea96e61e8bd1750de7d9fda
ToppCell	cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM4 ADAM23 SRPX PTGS1 MEIS2	6.75e-05	199	95	5	68412bc39639edc4045437d62548f7101b9f1989
ToppCell	Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 TENM4 PAK3 CYP46A1 UTP14C	6.75e-05	199	95	5	6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SHROOM4 ARHGAP23 ADAM23 SRPX MEIS2	6.75e-05	199	95	5	9c753043024871b1f1436fc39defac4da85e10cd
ToppCell	Parenchymal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 TENM4 PAK3 CYP46A1 UTP14C	6.75e-05	199	95	5	1aa99d21bf61b86df4a966dc47634044430aa39f
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SHROOM4 ARHGAP23 ADAM23 SRPX MEIS2	6.75e-05	199	95	5	d017dd91f9b10038f1f83753a766e534da2dbe89
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SEL1L3 CYP46A1 PTGS1 FERMT3 RASGRP2	6.92e-05	200	95	5	326cae37cacd94b423a6ac8873ea56c5abaf0a0b
ToppCell	distal-2-Endothelial-Vein\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SHROOM4 ARHGAP23 ADAM23 SRPX PTGS1	6.92e-05	200	95	5	2785225956d2422acab90e99b7debe3709cf3308
ToppCell	LPS_only-Myeloid-Dendritic_cells-pDC\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO7B SEL1L3 CLNK GRAMD4	2.00e-04	135	95	4	0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GRK5 PAK3 MEIS3 MEIS2	2.62e-04	145	95	4	051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BRDT REM2 CTSV DNAH14	2.69e-04	146	95	4	1bf67a9416f52198931b912a31be4bab09fefd19
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLIT2 TFCP2L1 CLNK SH3BP4	2.99e-04	150	95	4	87968ce885a4959616f0321f58517fe8029ba1b1
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	BRDT REM2 CTSV DNAH14	3.14e-04	152	95	4	b8aa62e3cf2b4c252db4bccfa75d881c4fa0a788
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ARHGAP23 MEIS3 BRWD3 NOL8	3.22e-04	153	95	4	e7d20c88466ff81db613869cf7a6a4bb95fd6c2f
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-Tfh\|blood / Manually curated celltypes from each tissue	GABRB3 ADAM23 RRS1 RPL10	3.30e-04	154	95	4	5ff380205fa7ab97ba21f6512bc9e14c0fb320b6
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARSB OAS3 CLNK RFC4	3.46e-04	156	95	4	33deda19f06172079ef1dd49fd54d66da1e7fb14
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARSB CLNK RFC4 E2F8	3.55e-04	157	95	4	8b2a85de2b1b56b9aa250b48c09e19f8f05708cd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	OTOP1 RIPOR3 MEIS2 RASGRP2	3.72e-04	159	95	4	e812cbde59188924c6277c3feadf1a9592fa62a4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	OTOP1 RIPOR3 MEIS2 RASGRP2	3.72e-04	159	95	4	2607b562903228274fbd96168ba826782fab0b53
ToppCell	severe_COVID-19-pDC\|severe_COVID-19 / disease group, cell group and cell class (v2)	PDE6H CHAF1A CTSV SH3BP4	3.72e-04	159	95	4	ea5088d27e42b8850455764d53b757ea8d8f14bc
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 PAK3 WDR25 FERMT3	3.81e-04	160	95	4	b2d8940ea8c068273b7da1589d3d6ae5110d8209
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 PAK3 WDR25 FERMT3	3.81e-04	160	95	4	9caab1bb63c7e66c44783852ee75b16bb40fa594
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 PAK3 WDR25 FERMT3	3.81e-04	160	95	4	229841be7b984a00a301cd5d88c11226a90d8a88
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DRC7 PAK3 WDR25 FERMT3	3.81e-04	160	95	4	99c9ae2041445539fada842e1af01368669bfca0
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CEP162 WDR25 CCDC38 E2F8	4.09e-04	163	95	4	3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLIT2 TFCP2L1 PARL CLNK	4.28e-04	165	95	4	9bd332e5ede759a00a47728ea5558c215efdd77a
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RIPOR3 PTGS1 FERMT3 RASGRP2	4.28e-04	165	95	4	d2ab667ff53f538b12ee4e07ea4b4d118600a228
ToppCell	severe-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SRPX CYP46A1 CTSV SH3BP4	4.38e-04	166	95	4	ae38850fde549b8dd6fb12f0ef80b428ade50485
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4\|TCGA-Colorectal / Sample_Type by Project: Shred V9	PABPN1 MTERF2 RRS1 ZNF692	4.38e-04	166	95	4	52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHAF1A SEL1L3 CLNK CYP46A1	4.38e-04	166	95	4	c8a7d94ed762e5e045ab5f74eef691ddc5f74993
ToppCell	wk_20-22-Hematologic-Myeloid-Mast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FAR2 CLNK PTGS1 MEIS2	4.38e-04	166	95	4	004ab6a1425d812c7ce572205875fd702d4a9659
ToppCell	Basal_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	ARHGAP23 BCAT2 UNC13C CTSV	4.38e-04	166	95	4	aea2ae12e4746149ebc6da063ef694381c098f80
ToppCell	10x5'-Lung-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|Lung / Manually curated celltypes from each tissue	DNHD1 CLNK RFC4 CDC42EP1	4.48e-04	167	95	4	dcbcc658082910838c8082d71a64917055086cc4
ToppCell	10x5'-Lung-Myeloid_Dendritic-pDC\|Lung / Manually curated celltypes from each tissue	ARHGAP23 SEL1L3 SRPX CYP46A1	4.58e-04	168	95	4	90f713dae3fcbd6ca801a019e3861c263ff3366b
ToppCell	ASK428-Immune-Mast_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	CTTNBP2 PTGS1 MEIS2 RPL10	4.58e-04	168	95	4	c399fcb4d1d0be48026c2ecabc34a5935e7adf73
ToppCell	NS-critical-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TFCP2L1 CTTNBP2 UNC13C CLNK	4.58e-04	168	95	4	6a233045638cb83dab64789b996b7598c325001e
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC\|lymph-node_spleen / Manually curated celltypes from each tissue	CHAF1A SRPX CYP46A1 SH3BP4	4.58e-04	168	95	4	cfed36fece51871a5abbcde71f6bd5e7212357ff
ToppCell	Control-Hematopoietic_Meg-Ery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	R3HDM4 RIPOR3 PTGS1 RPL10	4.69e-04	169	95	4	c2e2a7b89fe4a64d79efafdec037c4104f433061
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)\|356C / Donor, Lineage, Cell class and subclass (all cells)	SHROOM4 ARHGAP23 SRPX MEIS2	4.69e-04	169	95	4	605cc2638271803cf1d972ab3fa8f13f89666376
ToppCell	Control-Hematopoietic_Meg-Ery-Erythroid\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	R3HDM4 RIPOR3 PTGS1 RPL10	4.69e-04	169	95	4	df1fc1477bbbb285063b9b122b1ac84c87fd7fa8
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DRC7 FAR2 RFC4 E2F8	4.69e-04	169	95	4	481e611b5fface58f1630f206c0b04fb54e24011
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	SHROOM4 ARHGAP23 SRPX MEIS2	4.69e-04	169	95	4	337be3bf485b54afad86e256cb0c4c1d0c2a9a2a
ToppCell	NS-critical-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SHROOM4 TFCP2L1 MEIS2 SH3BP4	4.69e-04	169	95	4	aec97583b23112060437b619cb429dc32f29285f
ToppCell	Control-Hematopoietic_Meg-Ery-Erythroid-Erythroid\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	R3HDM4 RIPOR3 PTGS1 RPL10	4.69e-04	169	95	4	92986559aa4a744e8b0487b0ae035cfb1fbf9890
ToppCell	wk_15-18-Hematologic-Meg-ery-Megakaryocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	RIPOR3 PTGS1 FERMT3 RASGRP2	4.69e-04	169	95	4	d571e84e01e3316748d4407ed98881b17484e035
ToppCell	Control-Myeloid-Mast\|Control / Disease state, Lineage and Cell class	CTTNBP2 PTGS1 MEIS2 RPL10	4.79e-04	170	95	4	9a14deb7f7cd4a49c217eba4023f7bf1dec6c902
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	RIPOR3 PTGS1 FERMT3 RASGRP2	4.79e-04	170	95	4	3886a77bc3ddbeb42a8149b759fe578871676d6e
ToppCell	343B-Endothelial_cells-Endothelial-D\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ADAM23 SRPX PTGS1 RPL10	4.79e-04	170	95	4	52fdf93c2803fecb2a640ef4e0b257786f3d4cb1
ToppCell	343B-Endothelial_cells-Endothelial-D-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ADAM23 SRPX PTGS1 RPL10	4.79e-04	170	95	4	263e98aa1c49493cc262b2608c6582930841cb10
ToppCell	TCGA-Prostate-Solid_Tissue_Normal-Prostate_normal_tissue-Prostate_normal_tissue-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	CTTNBP2 PAK3 PTGS1 MEIS2	4.90e-04	171	95	4	cafcb7714110cb361808dbe4b9a4963bb71f5129
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARSB CHAF1A RFC4 PTGS1	4.90e-04	171	95	4	dca4aa921896ec935fb7acdf25a62d8eba679602
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARSB CHAF1A RFC4 PTGS1	4.90e-04	171	95	4	add2f7d34889ec654b8c71b4b1f084736111dc88
ToppCell	390C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CHAF1A SEL1L3 CTSV SH3BP4	5.01e-04	172	95	4	3f894c74916d49a995b2d4651ca1c6733c14ce9c
ToppCell	cellseq-Immune-Hematopoietic-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	R3HDM4 UBL4A PTGS1 FERMT3	5.01e-04	172	95	4	d0c3fb48c61762dcefca858cf13c9da8eb6d0f5e
ToppCell	cellseq-Immune-Hematopoietic-Megakaryocyte/Platelet\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	R3HDM4 UBL4A PTGS1 FERMT3	5.01e-04	172	95	4	eb2915165cab2660511e4b70c3a6d3ab2f770809
ToppCell	Mild-CD4+_T_Exhausted\|World / Disease group and Cell class	CHMP7 CD5 ZBTB7B RASGRP2	5.01e-04	172	95	4	efe68d9477aa873b1637ee689f298120303aa322
ToppCell	Endothelial-Endothelial-G\|Endothelial / shred on cell class and cell subclass (v4)	CD5 SEL1L3 PAK3 RIPOR3	5.01e-04	172	95	4	644f8e42ee8d8996f6ae50cdf874559be55509fc
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Mast_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CTTNBP2 SLC22A8 CLNK PTGS1	5.12e-04	173	95	4	a7dee23b1d43d3070d502487af319ff81a9a747b
ToppCell	Ionocyte-iono-2\|World / Class top	TFCP2L1 GRK5 CLNK SH3BP4	5.12e-04	173	95	4	e5ec28ccc5e048fd98de4c876e5c53b866b66228
ToppCell	TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4\|TCGA-Adrenal / Sample_Type by Project: Shred V9	CHAF1A CHD2 CTSV SH3BP4	5.23e-04	174	95	4	15e2b9f46404ff9575e149024b24cb17b50b02b5
ToppCell	mild_COVID-19-pDC\|mild_COVID-19 / disease group, cell group and cell class (v2)	SRPX FAM186B CYP46A1 SH3BP4	5.34e-04	175	95	4	b87f279a7519710146c49d6acccb0adedc195965
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Megakaryocyte\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DRC7 PTGS1 FERMT3 RASGRP2	5.34e-04	175	95	4	901f0181a30e5cc609dcada8d8a59f0468df6fa5
ToppCell	AT1-AT2_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	SHROOM4 ARHGAP23 GRK5 SAMD4A	5.34e-04	175	95	4	9a95ab5c361ebaa8747983c5a0d69025682a19ad
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RIPOR3 PTGS1 FERMT3 RASGRP2	5.34e-04	175	95	4	b85279b9efd72d7074c4226d50ce139a38c0e1c1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLIT2 TFCP2L1 CLNK SH3BP4	5.34e-04	175	95	4	77c16e615c0fb9c83f29d7e0a547be72635fac81
Drug	Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	RPL10L EHBP1L1 CEP162 ZC3H7B EXOC7 MXD4 DENND4C SAMD4A	1.38e-06	193	94	8	3293_DN
Drug	FK-506; Down 200; 1uM; MCF7; HG-U133A	MBTPS1 SIDT2 ADAM23 CEP162 UBL4A KIF3C DENND4C RPL10	1.80e-06	200	94	8	378_DN
Drug	tiaramide	SLC22A8 CLNK PTGS1	1.10e-05	11	94	3	CID000005469
Drug	PHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A	MBTPS1 R3HDM4 PABPN1 DHX38 OAS3 MXD4 RPL10	1.71e-05	196	94	7	6591_UP
Drug	Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A	RPL10L SIDT2 EHBP1L1 IKBKE PI4K2A ZC3H7B MXD4	1.77e-05	197	94	7	5349_UP
Drug	Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A	CEP162 WDR25 ZC3H7B EXOC7 MXD4 RPL10 SAMD4A	1.77e-05	197	94	7	7464_UP
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; HL60; HT_HG-U133A	MBTPS1 SIDT2 PDE6H PI4K2A EXOC7 SAMD4A RASGRP2	1.77e-05	197	94	7	2172_DN
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A	SLIT2 IKBKE PI4K2A ZC3H7B EXOC7 PTGS1 SAMD4A	1.77e-05	197	94	7	5410_DN
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A	TENM4 PI4K2A PAK3 ZC3H7B PTGS1 RPL10 SAMD4A	1.77e-05	197	94	7	2308_UP
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A	RPL10L ARSB PI4K2A KIF3C ZC3H7B EXOC7 CDC42EP1	1.77e-05	197	94	7	1695_UP
Drug	monastrol; Down 200; 20uM; MCF7; HG-U133A	RPL10L GRK5 NEMF EXOC7 MXD4 ACSL5 SAMD4A	1.83e-05	198	94	7	605_DN
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	RPL10L SLIT2 CEP162 GRK5 OAS3 KIF3C MXD4	1.89e-05	199	94	7	5358_UP
Drug	poly r(A-U	IKBKE PABPN1 OAS3	1.89e-05	13	94	3	CID000032741
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRMU CHMP7 UBL4A ZNF692 RPL10 SAMD4A	8.00e-05	172	94	6	7179_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRMU PABPN1 BICRAL ZNF692 CREBBP SAMD4A	8.00e-05	172	94	6	2794_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BICRAL ZC3H7B EXOC7 ZNF692 CREBBP E2F8	1.03e-04	180	94	6	3688_DN
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	CEP162 OAS3 KIF3C EXOC7 MXD4 SAMD4A	1.13e-04	183	94	6	5221_UP
Drug	Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A	SIDT2 EHBP1L1 ARSB IKBKE ZC3H7B EXOC7	1.34e-04	189	94	6	2800_DN
Drug	Syrosingopine [84-36-6]; Up 200; 6uM; HL60; HG-U133A	SIDT2 CD5 CHAF1A GRK5 KIF3C MXD4	1.42e-04	191	94	6	1761_UP
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A	SLIT2 SIDT2 GRK5 ZC3H7B MXD4 SAMD4A	1.46e-04	192	94	6	5401_DN
Drug	Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; HL60; HG-U133A	SIDT2 SEL1L3 KIF3C EIF4G3 PTGS1 RASGRP2	1.46e-04	192	94	6	1589_UP
Drug	Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A	TRMU SLIT2 GRK5 OAS3 TTC17 ZC3H7B	1.46e-04	192	94	6	6044_DN
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A	RPL10L IKBKE PI4K2A EXOC7 GRAMD4 RPL10	1.51e-04	193	94	6	5440_DN
Drug	carbamazepine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	TRMU EHBP1L1 CEP162 KIF3C ZC3H7B ZNF692	1.51e-04	193	94	6	835_DN
Drug	phenanthridinone; Down 200; 51.2uM; MCF7; HT_HG-U133A_EA	TRMU MBTPS1 FAR2 CHAF1A TTC17 RB1CC1	1.55e-04	194	94	6	1115_DN
Drug	Avermectin B1 [71751-41-2]; Down 200; 4.8uM; MCF7; HT_HG-U133A	EHBP1L1 IKBKE CEP162 PI4K2A ZC3H7B EXOC7	1.55e-04	194	94	6	6081_DN
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	IKBKE KIF3C SRPX EXOC7 MXD4 RPL10	1.55e-04	194	94	6	5457_DN
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; PC3; HT_HG-U133A	TFCP2L1 SIDT2 GRK5 PI4K2A PAK3 SAMD4A	1.59e-04	195	94	6	4634_UP
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SLIT2 IKBKE PI4K2A OAS3 EXOC7 SAMD4A	1.59e-04	195	94	6	4980_DN
Drug	chlorpromazine hydrochloride; Up 200; 10uM; MCF7; HG-U133A	SIDT2 OAS3 EXOC7 CYP46A1 MXD4 ACSL5	1.59e-04	195	94	6	419_UP
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	SLIT2 SIDT2 ARSB PTGS1 MXD4 E2F8	1.59e-04	195	94	6	5228_DN
Drug	Risperidone [106266-06-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	IKBKE GRK5 PI4K2A OAS3 EXOC7 CDC42EP1	1.64e-04	196	94	6	3508_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	TFCP2L1 TENM4 IKBKE CREBBP PTGS1 CDC42EP1	1.64e-04	196	94	6	6060_UP
Drug	Bemegride [64-65-3]; Up 200; 25.8uM; MCF7; HT_HG-U133A	SIDT2 IKBKE OAS3 CREBBP ACSL5 SAMD4A	1.64e-04	196	94	6	5014_UP
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A	SIDT2 CEP162 EIF4G3 ZC3H7B EXOC7 CDC42EP1	1.68e-04	197	94	6	5949_UP
Drug	2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A	CHMP7 SIDT2 EHBP1L1 ZC3H7B CTSV RASGRP2	1.68e-04	197	94	6	6181_DN
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; HL60; HG-U133A	SIDT2 CILP GRK5 BICRAL ZC3H7B MXD4	1.68e-04	197	94	6	1591_UP
Drug	Naringin hydrate [11032-30-7]; Down 200; 6.6uM; MCF7; HT_HG-U133A	SIDT2 EHBP1L1 CEP162 PI4K2A WDR25 EXOC7	1.68e-04	197	94	6	5666_DN
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A	RPL10L ARSB PI4K2A SRPX PTGS1 MXD4	1.68e-04	197	94	6	6094_DN
Drug	Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A	ARSB CEP162 PI4K2A SRPX RB1CC1 EXOC7	1.68e-04	197	94	6	6261_UP
Drug	genistein; Down 200; 10uM; PC3; HG-U133A	MBTPS1 GRK5 EIF4G3 ZC3H7B EXOC7 MXD4	1.68e-04	197	94	6	703_DN
Drug	Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; HL60; HT_HG-U133A	RPL10L SIDT2 EHBP1L1 CEP162 ZNF692 RASGRP2	1.68e-04	197	94	6	2944_UP
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	RPL10L SIDT2 IKBKE PI4K2A EXOC7 PTGS1	1.68e-04	197	94	6	3865_DN
Drug	Natamycin [7681-93-8]; Up 200; 6uM; PC3; HT_HG-U133A	EHBP1L1 ZC3H7B MXD4 RPL10 SAMD4A RASGRP2	1.68e-04	197	94	6	5809_UP
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RPL10L EHBP1L1 CEP162 PI4K2A OAS3 ZC3H7B	1.68e-04	197	94	6	3924_DN
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A	EHBP1L1 GRK5 KIF3C WDR25 ZC3H7B PTGS1	1.68e-04	197	94	6	7482_UP
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SLIT2 SIDT2 EHBP1L1 IKBKE OAS3 RASGRP2	1.73e-04	198	94	6	2649_UP
Drug	Flumequine [42835-25-6]; Down 200; 15.4uM; MCF7; HT_HG-U133A	RPL10L SLIT2 EHBP1L1 CILP PI4K2A ZC3H7B	1.73e-04	198	94	6	2276_DN
Drug	rosiglitazone maleate; Up 200; 10uM; HL60; HG-U133A	SIDT2 EHBP1L1 ARSB GRK5 DHX38 MXD4	1.73e-04	198	94	6	369_UP
Drug	Racecadotril [81110-73-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	RPL10L GRK5 SRPX EXOC7 RPL10 SAMD4A	1.73e-04	198	94	6	6231_UP
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; PC3; HT_HG-U133A	SIDT2 EHBP1L1 CEP162 GRK5 PI4K2A CDC42EP1	1.73e-04	198	94	6	6351_UP
Drug	Methiazole; Up 200; 15uM; MCF7; HT_HG-U133A	TENM4 GRK5 PI4K2A CREBBP PTGS1 SAMD4A	1.78e-04	199	94	6	3878_UP
Drug	Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A	SLIT2 EHBP1L1 IKBKE ADAM23 PTGS1 RASGRP2	1.78e-04	199	94	6	6828_UP
Drug	Suxibuzone [27470-51-5]; Up 200; 9.2uM; PC3; HT_HG-U133A	TFCP2L1 EHBP1L1 WDR25 MXD4 RPL10 SAMD4A	1.78e-04	199	94	6	5806_UP
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; HL60; HT_HG-U133A	CEP162 PI4K2A ZC3H7B EXOC7 GRAMD4 RASGRP2	1.78e-04	199	94	6	2400_DN
Drug	Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A	SLIT2 ARSB CEP162 WDR25 PTGS1 MXD4	1.78e-04	199	94	6	1699_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; MCF7; HT_HG-U133A	CILP PI4K2A EXOC7 MXD4 SAMD4A RASGRP2	1.78e-04	199	94	6	4359_UP
Drug	clofibrate; Up 200; 100uM; MCF7; HG-U133A	SIDT2 CD5 DHX38 EIF4G3 EXOC7 DENND4C	1.78e-04	199	94	6	444_UP
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	MBTPS1 SIDT2 TENM4 PI4K2A KIF3C EXOC7	1.78e-04	199	94	6	6308_DN
Drug	Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; PC3; HT_HG-U133A	CHAF1A GRK5 SEL1L3 KIF3C ZC3H7B CDC42EP1	1.78e-04	199	94	6	5843_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A	SLIT2 EHBP1L1 PI4K2A ZC3H7B EXOC7 RPL10	1.83e-04	200	94	6	6034_DN
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A	SLIT2 BICRAL EXOC7 PTGS1 RPL10 CDC42EP1	1.83e-04	200	94	6	2648_UP
Drug	Etanidazole [22668-01-5]; Down 200; 18.6uM; HL60; HT_HG-U133A	TRMU CHMP7 PABPN1 CEP162 EXOC7 RASGRP2	1.83e-04	200	94	6	2510_DN
Disease	restless legs syndrome (implicated_via_orthology)	MEIS3P2 MEIS3 MEIS2 MEIS3P1	5.12e-09	8	88	4	DOID:0050425 (implicated_via_orthology)
Disease	leukemia (implicated_via_orthology)	MEIS3P2 MEIS3 MEIS2 MEIS3P1	2.77e-07	19	88	4	DOID:1240 (implicated_via_orthology)
Disease	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME	PAK3 BRWD3 RPL10	1.42e-06	8	88	3	C0796250
Disease	leukocyte adhesion deficiency 3 (implicated_via_orthology)	FERMT3 RASGRP2	8.79e-06	2	88	2	DOID:0110912 (implicated_via_orthology)
Disease	T-cell acute lymphoblastic leukemia (implicated_via_orthology)	RPL10L RPL10	2.63e-05	3	88	2	DOID:5603 (implicated_via_orthology)
Disease	amino acid measurement	SLIT2 TENM4 FAR2 PARL BCAT2 UNC13C KIF3C WDR25 CTSV MEIS2	3.46e-05	678	88	10	EFO_0005134
Disease	autistic disorder (implicated_via_orthology)	RPL10L RPL10	5.26e-05	4	88	2	DOID:12849 (implicated_via_orthology)
Disease	Autism Spectrum Disorders	GABRB3 CTTNBP2 NEMF CHD2	1.24e-04	85	88	4	C1510586
Disease	Lennox-Gastaut syndrome	GABRB3 CHD2	1.31e-04	6	88	2	C0238111
Disease	spondyloepiphyseal dysplasia congenita (implicated_via_orthology)	RPL10L RPL10	1.31e-04	6	88	2	DOID:14789 (implicated_via_orthology)
Disease	syndromic X-linked intellectual disability Najm type (implicated_via_orthology)	RPL10L RPL10	1.83e-04	7	88	2	DOID:0060807 (implicated_via_orthology)
Disease	IGFBP-3 measurement	GRK5 CREBBP NUBP2	5.70e-04	54	88	3	EFO_0004626
Disease	diet measurement	GABRB3 CTTNBP2 TENM4 ADAM23 UNC13C CHD2 ZC3H7B FAM186B DNAH14 FERMT3	1.13e-03	1049	88	10	EFO_0008111
Disease	response to methotrexate, juvenile idiopathic arthritis	GABRB3 CTTNBP2	1.45e-03	19	88	2	EFO_0002609, GO_0031427
Disease	nose morphology measurement, mouth morphology measurement	MEIS3 MEIS3P1	1.78e-03	21	88	2	EFO_0007843, EFO_0007955
Disease	disease	RPL10L BCAT2	1.78e-03	21	88	2	EFO_0000408
Disease	body fat percentage, coronary artery disease	DGKH CYP46A1	2.33e-03	24	88	2	EFO_0001645, EFO_0007800
Disease	antiphospholipid syndrome	GRK5 SH3BP4	2.33e-03	24	88	2	EFO_0002689
Disease	HMG CoA reductase inhibitor use measurement	LRPPRC DHX38 DENND4C FERMT3	2.50e-03	189	88	4	EFO_0009932
Disease	alcohol use disorder (implicated_via_orthology)	GRK5 UNC13C CREBBP CTSV	2.80e-03	195	88	4	DOID:1574 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
FKNVKKRRFDPTQQG	ADAM23	816	O75077
RNQPKKRKQQFIGLK	BRDT	486	Q58F21
RNQKFRKGKVFREPL	CTSV	96	O60911
RRLKRGAKPVTNFVK	GRAMD4	206	Q6IC98
FRKIKPQKSGRVLAL	CD5	251	P06127
GRPRKENKFSAKRLQ	CREBBP	1316	Q92793
PGKAKSFRNRVLPVK	BRWD3	1536	Q6RI45
IQTRPKRKLRKQHGN	BRWD3	1646	Q6RI45
SQQRDPKGKKRFILL	FAM186B	66	Q8IYM0
NPKRQKPAKFLRNIV	DNHD1	3806	Q96M86
KPAKFLRNIVRAQGK	DNHD1	3811	Q96M86
FLAKGKRFRVLQPVK	CHAF1A	671	Q13111
RGPKKNALIKQFVSD	NUBP2	106	Q9Y5Y2
VPKAKGRKSLQRLEN	R3HDM4	61	Q96D70
QAKKAQNRFKVPLGT	RB1CC1	1566	Q8TDY2
AGIPKAKQRLKRLRN	FAR2	451	Q96K12
EKNKKARLRSIFPGG	PAK3	41	O75914
KTKAAGLVRKAPNNR	MXD4	41	Q14582
RLFAKKQPGQLRTRL	LZIC	96	Q8WZA0
GKVKVSAPNLLNVKR	NEMF	1061	O60524
FFVVQINKAKSRPKR	MBTPS1	1016	Q14703
RNPVGQKKRKMSLLF	RASGRP2	136	Q7LDG7
QKHVKKPEGLFRNRF	TRMU	141	O75648
RQKKRGIFPKVATNI	MEIS2	276	O14770
ERAVLRKPQQKAFGV	IKBKE	186	Q14164
LRFANRAKNIKNKPR	KIF3C	356	O14782
NLAQKKRRLKGQIPE	VBP1	66	P61758
KRLQRVGKRAAKFQF	EHBP1L1	6	Q8N3D4
LRPANKLAKGNRLFM	NCBP3	246	Q53F19
RRNKKRGIFPKVATN	MEIS3	261	Q99687
RTGRIPKKLLQKVFN	LRPPRC	96	P42704
FFGRGPQRQKKLAEK	GABRB3	331	P28472
RFKIKPQFEGRAGQK	NOL8	851	Q76FK4
GKKQLPDAQLLARRF	PTGS1	166	P23219
GVKFLRRFKQLLNPA	DGKH	346	Q86XP1
VKRPGTIRKAQNLLK	EXOC7	266	Q9UPT5
QEPRRNKKRGIFPKV	MEIS3P2	241	A8K0S8
ANFGKIQAKKVRPLF	MTERF2	361	Q49AM1
LALEKVPKVGQRFNR	PI4K2A	236	Q9BTU6
PVGRKRSRKAAKAQL	FAM9A	46	Q8IZU1
LFRGRQIKVIPKRTN	PABPN1	236	Q86U42
PRFLQGNAKRKVLRN	OTOP1	531	Q7RTM1
KRPAAKQLTKGAFIL	BICRAL	691	Q6AI39
FKNILELKKAGRQPQ	BICRAL	1011	Q6AI39
RQKVKVQLARSGPCK	E2F8	456	A0AVK6
RNTLAKFLPGKRKQL	CYP46A1	226	Q9Y6A2
LKQRPRFVALKKQPA	CHD2	461	O14647
LQRFLRRKVVNKFKG	CTTNBP2	1281	Q8WZ74
RRKVVNKFKGQAPSP	CTTNBP2	1286	Q8WZ74
NGEKIVKFARGPRAK	CHMP7	216	Q8WUX9
FLAKKLQLVRRVGAP	CDC42EP1	81	Q00587
NVVRGLAQFRQPLKK	DENND4C	886	Q5VZ89
PNGTLKIIDRKKNIF	ACSL5	531	Q9ULC5
GNPSIRQKIRLKDKA	CEP162	901	Q5TB80
PKKLNIVRRAFKGSA	DNAH14	3376	Q0VDD8
RCPNGKKVIQYKRAK	DRC7	431	Q8IY82
FVASPLLKQKGVKNR	ARSB	331	P15848
AQPKKKLGRRLVFHS	CCDC38	521	Q502W7
PKKGLLQRLFKRQHQ	GRK5	546	P34947
KAFKGKDQQVRLFRP	BCAT2	106	O15382
KALKILRRVAVFNGK	SLC22A8	271	Q8TCC7
KPGNTVNFRKLLLNR	EIF4G3	826	O43432
FVLQKKGIVRAKRRG	NIPA1	46	Q7RTP0
KTVGDFLKQQLQKPR	OAS3	1021	Q9Y6K5
RNKKRGIFPKVATNI	MEIS3P1	161	A6NDR6
FIQQKCGFRKAPRKV	PARL	46	Q9H300
ALRRAKFKFPGRQKI	RPL10L	151	Q96L21
KFRFKPLSDKIQQQR	RFC4	196	P35249
VLFKGQGVKKNRRLA	SEL1L3	736	Q68CR1
VLNKQKGAPLLFVVR	SIDT2	71	Q8NBJ9
AIKPSGQRRFLKKNE	SH3BP4	616	Q9P0V3
ALRRAKFKFPGRQKI	RPL10	151	P27635
NFLKRQKAPRSKLIS	TAF1A	281	Q15573
IQRRKAQLQKSKGPL	SHROOM4	596	Q9ULL8
AKVEVNIPRKRKGNC	PELO	161	Q9BRX2
KVRVKRCGKLNAPEN	SRPX	256	P78539
IRLFNAIKGRNVRPK	TFCP2L1	356	Q9NZI6
NIKGDASVRKNKIPL	CLNK	146	Q7Z7G1
RRVQPGKKNPSIFAK	CILP	31	O75339
KGPPKFKQRQTRQFK	PDE6H	21	Q13956
VGLKPSAKKRRQFLI	UTP14C	636	Q5TAP6
SRKPRKAFLQTKGAR	ZBTB7B	201	O15156
KNKRRTKTIFGNLNP	UNC13C	1251	Q8NB66
PQQVKKIFEALKRGL	RIPOR3	71	Q96MK2
IIKKNKKAAPRAFGV	ARHGAP23	891	Q9P227
QFARLKGIRPKKKTN	RRS1	116	Q15050
RKKRAIYPNEGFLKQ	STYXL2	256	Q5VZP5
QPEGVARILNKKAAK	SOGA1	1326	O94964
GNIRIRFIRKNKPFL	TENM4	1556	Q6N022
LQAKIFQKAPDGVRK	DHX38	786	Q92620
TGIFKKLPQLRKINF	SLIT2	551	O94813
LVAPRFQRKFKAKQL	FERMT3	506	Q86UX7
FQRKFKAKQLTPRIL	FERMT3	511	Q86UX7
KAKRFLANLVPRNAK	REM2	311	Q8IYK8
ALQARPGFEQAIKRK	TTC17	321	Q96AE7
VPVRQQRLLFKGKAL	UBL4A	36	P11441
AARFKQVKLSRNFPK	WDR25	131	Q64LD2
KQQVQKLFRSFPRKT	SAMD4A	546	Q9UPU9
TAQIGPKRIRKAAKR	ZNF692	311	Q9BU19
QKLGLRVRKAYKRPQ	ZC3H7B	161	Q9UGR2
QKSQGALPAKKRRSI	MYO7B	891	Q6PIF6